67 related articles for article (PubMed ID: 7478957)
1. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
[TBL] [Abstract][Full Text] [Related]
2. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
[TBL] [Abstract][Full Text] [Related]
4. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
[TBL] [Abstract][Full Text] [Related]
5. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
Ergen FB; Akata D; Sarikaya B; Kerimoglu U; Hayran M; Akhan O; Hussain HK
J Comput Assist Tomogr; 2008; 32(1):54-60. PubMed ID: 18303288
[TBL] [Abstract][Full Text] [Related]
6. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
[TBL] [Abstract][Full Text] [Related]
7. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
[TBL] [Abstract][Full Text] [Related]
8. [MR imaging oral contrast agent mixed with milk for the small intestine].
Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
[TBL] [Abstract][Full Text] [Related]
9. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
[TBL] [Abstract][Full Text] [Related]
10. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
[TBL] [Abstract][Full Text] [Related]
11. [Use of oral superparamagnetic contrast media in cholangiopancreatography with TSE single-shot magnetic resonance].
Blandino A; Gaeta M; Mazziotti S; Settineri N; Pandolfo I
Radiol Med; 1998; 96(1-2):87-91. PubMed ID: 9819624
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of Abdoscan in MRI cholangio-pancreatography and MRI urography].
Lecesne R; Drouillard J; Cissé R; Schiratti M
J Radiol; 1998 Jun; 79(6):573-5. PubMed ID: 9757288
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal contrast agents for MR imaging.
Brown JJ
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
[TBL] [Abstract][Full Text] [Related]
14. [Elimination of artifacts in MRCP: technical consideration].
Ohgi K; Satoh K; Tanaka S; Higami T; Furukawa T; Akiyama H; Kimura S; Uehara K; Murata K; Higashi M
Nihon Rinsho; 1998 Nov; 56(11):2854-8. PubMed ID: 9847609
[TBL] [Abstract][Full Text] [Related]
15. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial.
Boraschi P; Braccini G; Gigoni R; Cartei F; Perri G
Magn Reson Imaging; 2004 Oct; 22(8):1085-95. PubMed ID: 15527995
[TBL] [Abstract][Full Text] [Related]
16. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer.
Ryoo I; Lee JM; Chung YE; Park HS; Kim SH; Han JK; Choi BI
Invest Radiol; 2010 Apr; 45(4):217-24. PubMed ID: 20195160
[TBL] [Abstract][Full Text] [Related]
17. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
18. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparative study of negative oral contrast agents for magnetic resonance cholangiopancreatography.
Morita S; Ueno E; Masukawa A; Suzuki K; Fujimura M; Hirabayashi N; Kojima S; Hirata M; Kitajima K; Kaji Y
Jpn J Radiol; 2010 Feb; 28(2):117-22. PubMed ID: 20182846
[TBL] [Abstract][Full Text] [Related]
20. Technical note: dynamic analysis of the pharynx during swallowing using Turbo-FLASH magnetic resonance imaging combined with an oral positive contrast agent--a preliminary study.
Suto Y; Kamba M; Kato T
Br J Radiol; 1995 Oct; 68(814):1099-102. PubMed ID: 7496712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
